Discontinued products

Lundbeck Ireland Ltd.

Orion Corporation regrets to inform you that they have ceased supply of Vantas (histrelin) implant for advanced prostate cancer in Ireland.

Lundbeck (Ireland) Ltd wishes to announce the discontinuation of the following products from the Irish market for commercial reasons: •        Clopixol Acuphase 50mg/ml solution for injection •        Depixol 200mg/ml solution for injection Please note that all other presentations in the Clopixol and Depixol product ranges will remain on the Irish market – Clopixol 10mg film-coated tablets, Clopixol 200mg/ml and 500mg/ml

Merck Serono Ltd would like to inform you that Glucophage (metformin) 500mg powder for oral solution has been discontinued due to unforeseen manufacturing issues.

Boehringer Ingelheim Ltd would like to inform you that Viramune (nevirapine) 50mg prolonged-release tablets will be discontinued at the end of December 2014 for commercial reasons.

Novartis Ireland would like to advise you that Starlix, an oral antidiabetic agent used in the management of Type 2 diabetes mellitus, has been discontinued for the Irish market.

Amgen Ireland Ltd wishes to inform you that due to commercial reasons, a decision has been made to discontinue the 15μg dose of Aranesp prefilled syringe.

Eli Lilly & Co.

Roche Products (Ireland) Ltd wish to notify you of a stock-out of the following presentations of Tamiflu hard capsules at their primary distributor, AllPhar Services Ltd: • Tamiflu 30mg hard capsules (EU/1/02/222/003) • Tamiflu 45mg hard capsules (EU/1/02/222/004) • Tamiflu 75mg hard capsules (EU/1/02/222/001) The next stock delivery for the above presentations will be for the 2013-2014 flu season and

Roche Products (Ireland) Ltd wish to inform you of the discontinuation of Tamiflu 12mg/ml powder for oral suspension.